English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/162320
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Título

Benznidazole Nanoformulates: A Chance to Improve Therapeutics for Chagas Disease

AutorVinuesa, Teresa; Herráez, Rocio; Oliver, Laura; Elizondo, Elisa ; Acarregui, Argia; Esquisabel, Amaia; Pedraz, Jose Luis; Ventosa, Nora ; Veciana, Jaume ; Viñas, Miguel
Palabras claveExpressing beta-galactosidase
Trypanosoma-cruzi epimastigotes
Drug discovery
Nanoparticles
Cyclodextrin
Nanomaterials
Fecha de publicaciónnov-2017
EditorAmerican Society of Tropical Medicine and Hygiene
CitaciónAmerican Journal of Tropical Medicine and Hygiene 97(5): 1469-1476 (2017)
ResumenThis article describes the characterization of various encapsulated formulations of benznidazole, the current first-line drug for the treatment of Chagas disease. Given the adverse effects of benznidazole, safer formulations of this drug have a great interest. In fact, treatment of Chagas disease with benznidazole has to be discontinued in as much as 20% of cases due to side effects. Furthermore, modification of delivery and formulations could have potential effects on the emergence of drug resistance. The trypanocidal activity of new nanostructured formulations of benznidazole to eliminate Trypanosoma cruzi was studied in vitro as well as their toxicity in two cultured mammalian cell lines (HepG2 and Fibroblasts). Nanoparticles tested included nanostructured lipid carriers, solid lipid nanoparticles, liposomes, quatsomes, and cyclodextrins. The in vitro cytotoxicity of cyclodextrins–benznidazole complexes was significantly lower than that of free benznidazole, whereas their trypanocidal activity was not hampered. These results suggest that nanostructured particles may offer improved therapeutics for Chagas disease.
Versión del editorhttp://dx.doi.org/10.4269/ajtmh.17-0044
URIhttp://hdl.handle.net/10261/162320
ISSN0002-9637
Aparece en las colecciones: (ICMAB) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Vinuesa_AmerJTropMedHyg_2017_editorial.pdf895,98 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.